Immix Biopharma【IMMX】株式ニュース

名称	銘柄コード	市場	種別
Immix Biopharma Inc	IMMX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0006	-0.03%	2.1494	21:00:00

始値	安値	高値	終値	前日終値
				2.15

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/22	05:05	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2024/5/21	06:27	EDGAR2	Form 8-K - Current report
2024/5/21	06:27	EDGAR2	Form D - Notice of Exempt Offering of Securities
2024/5/21	06:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	06:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	06:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	06:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	10:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	10:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/10	05:27	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/08	07:15	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/06	23:09	EDGAR2	Form 8-K - Current report
2024/2/06	06:38	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/06	06:37	EDGAR2	Form 8-K - Current report
2023/12/13	08:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/29	00:48	IHNW	Immix Biopharma Announces FDA Approval of IND Application..
2023/9/26	05:15	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2023/9/19	08:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/16	07:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/9/13	05:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/31	05:15	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2023/8/24	05:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/23	05:05	EDGAR2	Form 8-K - Current report
2023/8/15	05:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/15	05:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/15	05:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/15	05:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/12	05:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/25	21:42	GLOBE	Immix Biopharma Subsidiary Nexcella Announces NXC-201..
2023/7/17	22:37	GLOBE	Immix Biopharma Reports 2nd Positive Interim Clinical Trial..
2023/7/15	06:28	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/15	06:26	EDGAR2	Form 8-K - Current report
2023/7/10	22:47	GLOBE	Immix Biopharma Subsidiary Nexcella Completes Initial..
2023/6/26	22:49	GLOBE	Immix Biopharma Subsidiary Nexcella Completes Pre-IND..
2023/6/22	22:53	GLOBE	Immix Biopharma Subsidiary Nexcella Appoints Edward J...
2023/6/20	22:45	GLOBE	Immix Biopharma Subsidiary Nexcella Appoints Jeffrey H...
2023/6/16	22:43	GLOBE	Immix Biopharma Subsidiary Nexcella Appoints Mary Sue..
2023/6/14	20:30	GLOBE	Immix Biopharma Completes $5 Million At-The-Market Equity..
2023/6/12	22:49	GLOBE	Immix Biopharma Subsidiary Nexcella Appoints Henry..
2023/5/26	22:53	GLOBE	Immix Biopharma Subsidiary Nexcella Announces Commencement..